BioCentury
ARTICLE | Company News

Biomira, Merck KGaA deal

August 13, 2007 7:00 AM UTC

The partners added Canada to MRK's license covering BRA's Stimuvax cancer vaccine. MRK now has worldwide rights to develop and market the liposomal vaccine containing a synthetic, 25-amino acid pepti...